港股異動 | 碧桂園(02007.HK)連續2日反彈 與招行強強聯手 機構指龍頭地位日益穩固
格隆匯3月7日丨碧桂園(02007.HK)逆勢漲7%,連續2日漲近15%。現報6.49港元,暫成交5.79億港元,總市值1502億港元。招行日前授予碧桂園150億元的併購融資額度,用於地產併購業務。天風證券指出,碧桂園與招行強強聯手,龍頭地位日益穩固。維持“買入”評級。此外,公司多次購回優先票據,表現公司在手現金充裕,具有較強風險控制能力。並且公司榮登2021年克而瑞房企銷售榜單榜首。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.